SEINE BIO · SCIENCE LIBRARY

hCG / Chorionic gonadotropin

hCG is a glycoprotein hormone with established reproductive-medicine uses.

Hormone / related medicine

A closer look at the research, the uncertainties and the questions worth asking.

THE FULL READING GUIDE · UPDATED OCTOBER 7, 2026

Inside the science of hCG / Chorionic gonadotropin.

Educational purpose only. Not medical advice. Consult licensed provider. Obtain from authorized compounding pharmacies only.

Compounding is appropriate only when lawful for the specific substance and patient; some substances may be unavailable. Finished FDA-approved medicines may also be dispensed by licensed non-compounding pharmacies.

Overview

Human chorionic gonadotropin, or hCG, is a reproductive glycoprotein hormone used in specific prescription contexts. It is not interchangeable with testosterone, a weight-loss medicine, or a universal fertility booster. Appropriate use depends on the underlying endocrine or reproductive diagnosis and the exact product being prescribed.

Community Use

PeptideDosages lists an hCG vial protocol, showing how a medically established hormone also appears in community discussions. That source does not define a universal regimen or justify post-cycle use. The clinical label and diagnosis take priority over a generic vial-strength chart. Observed community protocol.

Doses, Durations & Cycles

Published dosing regimens. Product-label and study regimens for education, not instructions for self-treatment. Product, indication and route matter.

Protocol reference — hCG / Chorionic gonadotropin
Route / formulation	Dose / reported phases	Frequency	Duration / break	Notes and source
Intramuscular	500–1,000 USP units per injection	Three times weekly for three weeks, then twice weekly for three weeks	Six weeks Break: No biohacking break established by this source	Pregnyl labeled male regimen 1 Pregnyl U.S. prescribing information, revised March 2025 Selected hypogonadotropic hypogonadism secondary to pituitary deficiency
Intramuscular	4,000 USP units initially; may reduce to 2,000 USP units	Three times weekly in both phases	Initial six to nine months; reduced-dose phase for three additional months Break: No biohacking break established by this source	Novarel labeled male regimen 2 Novarel U.S. prescribing information Selected hypogonadotropic hypogonadism secondary to pituitary deficiency

Important context: Pregnyl (BLA 017692) and Novarel (BLA 017016) have current U.S. prescription biologic label records. These labels include selected male hypogonadotropic hypogonadism. This establishes product and indication status, not pharmacy stock. Both audited U.S. labels specify intramuscular administration only; do not present subcutaneous administration as their labeled route. These entries concern Pregnyl and Novarel; do not transfer their male indication to recombinant hCG products. Units have not been converted to micrograms. Keep male hypogonadotropic hypogonadism separate from pediatric cryptorchidism and female ovulation induction. These are indication-specific labeled alternatives, not a clinical average, universal maximum, bodybuilding cycle, or PCT protocol.

Sources checked October 7, 2026. Educational listing does not establish prescribing approval or availability through Seine Bio.

hCG dosing uses biological units and indication-specific protocols, not a general peptide wellness cycle. Fertility care and selected male endocrine indications require different assessment and monitoring. A clinician should identify the exact product and goal; a strength on the package is not itself a prescription amount.

Research Findings

The reviewed PREGNYL prescribing document describes specific reproductive and endocrine uses and related monitoring. This is established clinical-product evidence, not a human trial validating every community purpose. It explicitly states that hCG has not been demonstrated effective as an adjunctive obesity treatment. PREGNYL prescribing information.

U.S. Approval & Access

Prescription hCG products have defined authorizations; these do not approve weight-loss use or a standardized bodybuilding recovery plan. Authorization should be verified for the actual formulation and indication. A medical product’s approval is not a blanket approval of every proposed use of its hormone.

What It Does in the Body

hCG acts through pathways related to luteinizing hormone activity. Depending on the clinical context, this can influence gonadal hormone production and reproductive processes. Onset and duration of a clinically meaningful outcome depend on the indication and protocol; a general wellness peak-effect claim is not established.

Benefits & Reported Experiences

The meaningful endpoint may be ovulation, another reproductive outcome, or response in a selected endocrine condition. These are different goals requiring different evidence. Raising a hormone marker alone does not establish success, and hCG should not be presented as producing weight loss independent of calorie restriction.

Side Effects & Risks

The label includes ovarian hyperstimulation and related reproductive risks in appropriate female treatment contexts, as well as fluid-retention and other precautions. Risks vary with indication and accompanying care. Review the full prescribing information and symptoms to report before starting a prescribed program.

Delivery Options

Different hCG products have their own formulation and route instructions. Urinary-derived and recombinant preparations are not interchangeable merely because their names are similar. This profile does not provide preparation or injection steps; product-specific training belongs with the clinician and dispenser.

Product Quality & Storage

Verify the licensed product, strength in units, dispensing source, and exact-label storage requirements. Do not use a generic peptide-storage rule for every hCG preparation. Patient instructions and any pharmacist directions should agree with the actual product, especially when formulation or packaging changes.

Combinations & Interactions

Fertility protocols may involve other prescribed medicines under specialist monitoring. That is distinct from a self-directed post-cycle stack. Other hormones or previous anabolic use should be disclosed, but the disclosure does not itself establish an indication for hCG or guarantee restoration of fertility.

Talking With Your Provider

Explain whether your goal concerns fertility, testosterone-related symptoms, or another diagnosed problem. Ask what testing identifies the cause and how success will be assessed. A consultation can distinguish an appropriate prescription pathway from a popular but unsupported use without promising the hormone in advance.

Educational purpose only. Not medical advice. Consult licensed provider. Obtain from authorized compounding pharmacies only.

Questions about what you read?
Explore the research library Create a free account
Educational information only. A free account lets you request review of your care goals. This profile does not establish availability, clinical suitability or access to the named compound.

Explore clinically appropriate options with a licensed provider. Inquiry does not guarantee a prescription, research-program acceptance or access to a particular substance.

Questions worth bringing to your appointment.

Are there alternatives that address my goal?
If treatment is appropriate, what monitoring and follow-up would I need?
Could my health history or current medicines change the risks?

Saved discussion topics 0

Save topics you would like to discuss with your healthcare provider. Saving is an expression of interest, not a treatment request or medical recommendation.

Saved only in this browser, on this device—not in a patient account. Other people using this browser may see your list. Clear it when using a shared device. This list is not sent to our team.

Explore your next step with SEINE BIO.

Bring your questions to a wellness consultation. Inclusion in this library does not indicate prescribing or product availability. A consultation does not guarantee a prescription.

Explore consultations Back to Hormones, anabolic steroids & related medicines

Educational information · U.S. context · October 7, 2026. No ordering, personalized dosing or injection instructions.

Bring your saved topics to your care team.

Members can select up to five favorites and send a message for review. Your saved list stays in this browser until you choose what to submit.

Choose saved topics for review →